Trial · NCT02878798
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Intraepidermal Nerve Fiber Density (IENFD) | 96 weeks | fibers/mm/year (52 weeks) | LEAST_SQUARES_MEAN | |
| PRIMARY | Norfolk Quality of Life - Diabetic Neuropathy | 96 weeks (expressed as a slope in change of total score/52 weeks) | Change inTotal NQOL-DN score over 52 wks | LEAST_SQUARES_MEAN | |
| SECONDARY | Brief Pain Inventory - Diabetic Neuropathy (BPI-DN) Pain Interference | 96 weeks (expressed as a change in change in pain interference/52weeks) | Slope of change in BPI-DN PI over 52 wks | LEAST_SQUARES_MEAN | |
| SECONDARY | Brief Pain Inventory - Diabetic Neuropathy (BPI-DN) Average Pain Intensity | 96 weeks (expressed as a slope of change over 52 weeks) | Slope of change in BPI-DN pain over 52 w | LEAST_SQUARES_MEAN | |
| SECONDARY | Utah Early Neuropathy Scale | 96 weeks (expressed as a slope of change in total UENS over 52 weeks). | Slope of change in Total UENS over 52wks | LEAST_SQUARES_MEAN | |
| SECONDARY | Sural Sensory Amplitude (SSA) | 96 weeks (slope of change in mV/52weeks) | slope of change in SSA uV over 52 wks | LEAST_SQUARES_MEAN | |
| SECONDARY | Peroneal Motor Conduction Velocity (PMCV) | 96 weeks (expressed as a slope of change in meter/sec over 52 weeks) | Slope of change in M/S over 52 wks | LEAST_SQUARES_MEAN | |
| SECONDARY | Body Mass Index (BMI) | 96 weeks (slope of change in kg/m2/52 weeks) | Slope of change in BMI kg/m2 over 52wks | LEAST_SQUARES_MEAN | |
| SECONDARY | Hemoglobin A1C | The annual slope of the change in A1C over 96 weeks expressed in change in percent/52 weeks | change in %/52 weeks over 96 weeks | LEAST_SQUARES_MEAN | |
| SECONDARY | Serum Triglycerides (TRG) | 96 weeks (slope of change mg/dl over 52 weeks) | change in mg/dl/52 weeks over 96 weeks | LEAST_SQUARES_MEAN | |
| SECONDARY | LDL Cholesterol | 96 weeks (expressed as a slope of change in mg/dl/52 weeks) | change in mg/dl/52 weeks at 96 weeks | LEAST_SQUARES_MEAN | |
| SECONDARY | HDL Cholesterol | 96 weeks (expressed as slope of change in mg/dL/52 weeks) | change in mg/dl/52 weeks at 96 weeks | LEAST_SQUARES_MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02878798/outcomes